DEROVAN NETANEL (Chief Legal Officer) received a stock award from ORAMED PHARMACEUTICALS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/31/2023ACC: 0001209191-23-033144
Officer· Chief Legal Officer
Since Jan 2022
+20.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
20.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+20.50K
Price / share
—
Trade value
—
% of position
15.9%
5/26/2023
129K→149.50K
Total
Net shares
+20.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/26/2023 | A · Award | +20.50K | — | — | 15.9% | 129K | 149.50K |
| Total | +20.50K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported